Applied Therapeutics (NASDAQ:APLT) was downgraded by analysts at Leerink Partners from an "outperform" rating to a "market perform" rating. They now have a $1.00 price target on the stock.
Applied Therapeutics (NASDAQ:APLT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Applied Therapeutics Announces Corporate Updates [Yahoo! Finance]
Applied Therapeutics Announces Corporate Updates
Can Changes in Leadership and FDA Dialogue Reshape Applied Therapeutics' (APLT) Path in Rare Diseases? [Yahoo! Finance]